Insider Transactions in Q1 2024 at Athira Pharma, Inc. (ATHA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2024
|
Mark James Litton President and CEO |
SELL
Open market or private sale
|
Direct |
4,820
-3.23%
|
$9,640
$2.91 P/Share
|
|
Jan 05
2024
|
Rachel Lenington COO and CDO |
SELL
Open market or private sale
|
Direct |
2,412
-15.26%
|
$4,824
$2.91 P/Share
|
|
Jan 05
2024
|
Mark Worthington General Counsel and CCO |
SELL
Open market or private sale
|
Direct |
2,412
-6.54%
|
$4,824
$2.91 P/Share
|
|
Jan 04
2024
|
Hans Moebius Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+9.85%
|
-
|
|
Jan 04
2024
|
Mark James Litton President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+11.82%
|
-
|
|
Jan 04
2024
|
Rachel Lenington COO and CDO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+38.75%
|
-
|
|
Jan 04
2024
|
Mark Worthington General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+21.34%
|
-
|